Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 16Mouth Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Tongue Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Nasopharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Papilloma 1Neoplasms 1Mucositis 1Leukoplakia, Oral 1Laryngeal papillomatosis 1Adenocarcinoma, Follicular 1

Interventions

Radiotherapy, Intensity-Modulated 1Narrow Band Imaging 1Microsurgery 1Lasers, Gas 1Laser Therapy 1Cisplatin 1Celecoxib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papilloma × Celecoxib × Head & Neck × Clear all
NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Boston University

Phase 2 Terminated
10 enrolled 6 charts
Head & Neck

Laryngeal papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡